Examinando por Autor "Carhuas Rivera, Yobely Humbertha"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Tratamiento farmacológico para el COVID-19 en pacientes que acudieron al Centro Médico Naval Cirujano Mayor Santiago Távara, Lima 2021
    (Universidad Privada Norbert Wiener, 2022-10-05) Carhuas Rivera, Yobely Humbertha; Quinto Sanchez, Sandy; Parreño Tipián, Juan Manuel
    This new disease, COVID-19, has been designated by the WHO as an infection caused by the novel coronavirus-19, which rapidly spread across China and subsequently affected countries worldwide, impacting both developed and underdeveloped nations with varying effects on public health. The main objective of this research was to determine the pharmacological treatments for COVID-19 in patients who visited the Naval Medical Center "Cirujano Mayor Santiago Távara" in Lima Province. A descriptive study was designed with a quantitative research approach, using a checklist as an instrument for data collection. A documentary analysis of medical records was conducted from October to December 2021, comprising a population of 1,008 adults. The results showed that 31.33% of patients were aged 41 to 50 years, with the majority being male (71.08%). Pharmacological treatments identified for COVID-19 included: Antibiotics such as azithromycin (50.60%) and ceftriaxone (40.96%), Analgesics and/or antipyretics such as paracetamol (97.60%) and metamizole sodium (73.49%), Anticoagulants such as enoxaparin 60mg (33.73%) and enoxaparin 40mg (30.12%), Corticosteroids such as dexamethasone (39.76%), Oxygen therapy using medicinal oxygen (87.95%). It is concluded that there is currently no specific scientific treatment to counter the progression of the SARS-CoV-2 coronavirus. Therefore, therapy is based on symptom control and support, following clinical guidelines provided by the Ministry of Health in each country and the WHO worldwide.